文献速递疼痛医学

全身利多卡因治疗急慢性疼痛的分子机制:叙述性综述

Molecular mechanisms of action of systemic lidocaine in acute and chronic pain: a narrative review.
PubMed 文献 · Br J Anaesth · 2019-07-11

该叙述性综述聚焦全身利多卡因在急慢性疼痛中产生镇痛作用的分子机制实验证据,涵盖外周及中枢神经系统作用,包括抑制异位放电、抑制炎症过程及调节抑制性与兴奋性神经传递,并指出未来研究方向。

要点

  • 全身利多卡因对术后急性痛和慢性神经病理性疼痛有镇痛作用。
  • 其镇痛机制不能仅用电压门控钠通道阻滞解释。
  • 机制涉及外周和中枢的异位放电抑制、炎症抑制和神经传递调节。

核心结论

  • 全身利多卡因的镇痛作用涉及外周和中枢神经系统的多重分子机制,超越单纯钠通道阻滞。

研究设计与样本

  • 叙述性综述,汇总全身利多卡因镇痛分子机制的实验证据。

主要发现

  • 利多卡因通过抑制异位放电、抑制炎症过程及调节抑制性与兴奋性神经传递发挥镇痛作用。

临床怎么用

  • 综述提示全身利多卡因可用于急性术后痛和慢性神经病理性疼痛的镇痛治疗。

局限性

  • 负责镇痛的具体分子机制仍不明确,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Systemic administration of the local anaesthetic lidocaine is antinociceptive in both acute and chronic pain states, especially in acute postoperative and chronic neuropathic pain. These effects cannot be explained by its voltage-gated sodium channel blocking properties alone, but the responsible mechanisms are still elusive. This narrative review focuses on available experimental evidence of the molecular mechanisms by which systemic lidocaine exerts its clinically documented analgesic effects. These include effects on the peripheral nervous system and CNS, where lidocaine acts via silencing ectopic discharges, suppression of inflammatory processes, and modulation of inhibitory and excitatory neurotransmission. We highlight promising objectives for future research to further unravel these antinociceptive mechanisms, which subsequently may facilitate the development of new analgesic strategies and therapies for acute and chronic pain.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Hermanns H, Hollmann MW, Stevens MF, et al. Molecular mechanisms of action of systemic lidocaine in acute and chronic pain: a narrative review. Br J Anaesth. 2019. PMID: 31303268. doi:10.1016/j.bja.2019.06.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。